KaloBios Vows No Predatory Drug Pricing After Bankruptcy
Pharmaceutical company KaloBios on Monday promised it wouldn't engage in price-gouging or other predatory pricing of its drugs, vowing instead to focus on affordability for patients and payers in the wake...To view the full article, register now.
Already a subscriber? Click here to view full article